Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 2,301–2,400 of 2,883
Li, Z., Chen, Y., Shi, H., Tang, P., & Zhang, X. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71737 · Cited by 3
Cellular senescence in skeletal muscle regeneration
Liu, X., & Wang, H. (2026) · Cell Regeneration · doi:10.1186/s13619-026-00287-9 · Cited by 2
Xu, S., Guo, J., Kang, Y., Wang, Q., Ming, Y., Chen, W., Wang, M., Huang, Z., Huang, Y. Q., & Jia, B. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03086-6 · Cited by 1
“Based on this mechanism, research has initiated the development of senolytics, agents that clear senescent cells, as a therapeutic strategy [114, 115].”
Libertini, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_26-1 · Cited by 1
Examining Autophagy and Mitophagy as Inducible Mechanisms of Cellular Remodelling
Bloemberg, D. (2017) · UWSpace (University of Waterloo) · Cited by 3
Canonical and novel strategies to delay or reverse aging
Gilmour, B. C., Bergersen, L. H., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00005-5 · Cited by 2
Is “Cellular Senescence” a Misnomer?Preprint
Gems, D., & Kern, C. C. (2022) · Preprints.org · doi:10.20944/preprints202207.0423.v1 · Cited by 1
Ji, J., Crespi, C. M., Yee, L. D., Zektser, Y., Al-Saleem, A., Petersen, L., Lee, C., Son, N., Smith, C. S., Evans, T. S., et al. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261424668 · Cited by 2
“…models demonstrated that by expressing an inducible suicide gene under the control of the p16 INK4a promoter, it is possible to ablate Sncs. 25,26 The elimination of Sncs improved age-related diseases and dysfunction, delayed tumor formation, and ameliorated many side effects of chemotherapy.”
Reproducible in vivo applications of the p16-3MR model in senescence researchPreprint
Wang, B., Picallos-Rabina, P., Nehme, J., & Demaria, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.28.701695 · Cited by 1
CXCL10/CXCR3 Signaling Induces Neural Senescence and Cognitive ImpairmentsPreprint
Patel, M., Kumar, S., Singh, A., & Yadav, P. N. (2024) · bioRxiv · doi:10.1101/2024.10.16.618653 · Cited by 1
“Multiple lines of evidence have demonstrated that senescent cells acquire “senescence-associated secretory phenotype (SASP)” and thereby recruit inflammatory cells, induce cell death, induce fibrosis, and inhibit resident stem cell functions (Baker et al., 2016; Jeon et al., 2017).”
BackgroundSingle-cell-based evidence for GLS1 inhibitor as a bona fide senolytic agent in vivoPreprint
Okamura, Y. T., Wang, T.-W., Kawakami, S., Morimura, T., Johmura, Y., & Nakanishi, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.22.666220 · Cited by 1
Yılmaz, S., Bedіr, E., & Ballar, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607434 · Cited by 1
Inflammaging: Expanding the Molecular Palette of Cellular ImmunophenotypePreprint
Иванов, Д. О., Дробинцева, А. О., Rodichkina, V. R., Mironova, E. S., Zubareva, T. S., Krylova, Y. S., Morozkina, S. N., Nasyrov, R. A., & Kvetnoy, I. M. (2024) · Preprints.org · doi:10.20944/preprints202404.0644.v1 · Cited by 1
Moving beyond the current limits of data analysis in longevity and healthy lifespan studies
Goh, W. W. B., Thalappilly, S., & Thibault, G. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.008 · Cited by 2
Pal, K., Raghuram, G. V., Dsouza, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.489500 · Cited by 1
Nitric oxide redox signaling as a convergent mechanism in aging and fibrosis
Guo, X., Cao, Y., Liu, L., Peng, Y., Du, Y., Yang, F., & Huang, D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103156 · Cited by 1
Jung, H. Y., Kwon, H. J., Hahn, K. R., Kim, W., Yoo, D. Y., Yoon, Y. S., Kim, D. W., & Hwang, I. K. (2023) · Aging · doi:10.18632/aging.205182 · Cited by 1
Senchyna, F., Schneider, K., Devrukhkar, P. R., Martin, N., Tran, T., Byrne, J., Watson, M. A., Wu, F., Belić, M., Fuentealba, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.02.703302 · Cited by 1
Yamanaka, Y., Tsujimura, Y., Naito, T., Sato, N., Tsukamoto, M., Suzuki, H., Zenke, Y., & Sakai, A. (2026) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.25.00807 · Cited by 1
Antioxidant properties and applications of Ophiopogon japonicus root for age-related disease
Kitahiro, Y., & Shibano, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818698-5.00027-4 · Cited by 1
The Pivotal Role of Senescence in Cell Death and Aging: Where Do We Stand?
Sadaf, S., Najm, M. Z., Shingatgeri, V., Uddin, M., Izhari, M. A., Akhtar, S., Kathait, A., Kar, S., Jain, I., Datt, P., et al. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00129-w · Cited by 1
Filardo, A., Coscarella, I., Bria, J., Vito, A. D., Torre, D. L., Chiarella, E., Giovinazzo, A., Procopio, E., Egiziano, M. T., Lavano, A., et al. (2026) · Cancers · doi:10.3390/cancers18081220 · Cited by 2
Oral administration of Lactobacillus kefiri Fanghua reduces immune senescence and aging phenotypes
Qiao, Z., Zhang, Y., Liu, H., Zou, H., Xie, Q., Liu, J., Zhang, H., Liu, T., Liu, Z., Qi, W., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250286 · Cited by 1
Dysfunctional TRPM8 signalling in the vascular response to environmental cold in ageingPreprint
Thapa, D., Valente, J. D. S., Barrett, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.10.443379 · Cited by 1
Biomaterial-Assisted Senescence-Targeting Treatment Strategy for Central Nervous System Injury
Zhao, Y., Luo, Y., Yang, J., Wu, J. C., & Wang, X. (2025) · Tissue Engineering Part B Reviews · doi:10.1177/19373341251359272 · Cited by 3
Trojan, E., Frydrych, J. K., Lasoń, W., & Basta‐Kaim, A. (2025) · Current Neuropharmacology · doi:10.2174/011570159x345385241004060055 · Cited by 2
“[72] have indicated that removing p16-positive cells benefits the surrounding tissue, delays aging, and increases the lifespan of mice.”
Sundaram, D. P., Vedagiri, H., Subbaraj, G. K., & Premkumar, K. (2024) · Springer eBooks · doi:10.1007/978-981-99-7269-2_15 · Cited by 1
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target
Légaré, C., Berglund, J. A., Duchesne, É., & Dumont, N. A. (2024) · BioEssays · doi:10.1002/bies.202400216 · Cited by 2
Hashimoto, M., Goto, A., Qiao, S., & Yamashita, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151454 · Cited by 1
Cellular Senescence in the Ascending Aorta and Complexity of Coronary Atherosclerosis
Abanus, H., Vural, M., Katkat, F., Paşaoğlu, E., Olgun, A., & Mert, B. (2026) · Journal of Aging Research · doi:10.1155/jare/9142131 · Cited by 3
“Furthermore, removal of p16-positive senescent cells from plaques in an animal model suppressed pathological atherosclerotic changes in LDL receptor-defcient mice [36, 37].”
Modelling the Dynamics of Senescence Spread
(2023) · doi:10.1101/2023.03.16.532939 · Cited by 1
Krishnamurthy, P., Rajamohamedsait, H. B., González‐Calle, V., Rajamohamedsait, W. J., Ahmed, N., Krishnaswamy, S., & Sigurdsson, E. M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00062 · Cited by 2
PRDM16 Reduces Cellular Senescence by Upregulating GSTM1
Qian, Y., Zhu, Y., Tang, B., Xie, Y., Hu, M., Su, H., Liu, Y., & Zhang, C. (2025) · Advanced Science · doi:10.1002/advs.202501233 · Cited by 5
Lin, Y., Altulea, A., & Demaria, M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103224 · Cited by 1
The Feasibility and Necessity of a Revolution in Geriatric Medicine
Italian Society for Evolutionary Biology, 1. A., & Libertini, G. (2017) · OBM Geriatrics · doi:10.21926/obm.geriat.1702002 · Cited by 15
Furuuchi, R., Yoshida, Y., Katsuumi, G., Furihata, T., Joki, Y., Hsiao, C. L., Suda, M., Saito, H., Kumazaki, T., Makabe, H., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115607 · Cited by 2
“10 13 To date, most senolytic agents have been developed on the basis of inhibition of antiapoptotic pathways activated in senescent cells.”
Wang, N., Wang, C., Wang, X., Meng, Y., Cui, S., Zhao, K., Jia, Y., & Kong, F. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189587 · Cited by 2
Procyanidin C1 is a natural agent with senolytic activity against aging and age-related diseases
Xu, Q., Fu, Q., Li, Z., Liu, H., Wang, Y., Lin, X., He, R., Zhang, X., Campisi, J., Kirkland, J., et al. (2021) · doi:10.21203/rs.3.rs-421222/v1 · Cited by 341
Palminha, N. M., Hashish, S. A., Rabie, E., & Saber, S. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-9205-5_4 · Cited by 1
Telomere Dynamics and Aging Related Diseases
Toupance, S., & Bénétos, A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781316677018.007 · Cited by 1
Characterisation of distinct senescent-like T cell populations during healthy and unhealthy ageingPreprint
Garrod-Ketchely, C., Callender, L. A., Schroth, J., Littlewood, K., Carroll, E. C., Tamsan, D., Tsang, V., Nessel, I., Riddell, N. E., Chain, B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.16.659752 · Cited by 1
Wang, Z., Deng, W., Yu, Q., Yu, J., & Xu, X. (2026) · Tissue Engineering Part B Reviews · doi:10.1177/19373341251372972 · Cited by 1
Senolytic treatment targets aberrant p21-expression to restore liver regeneration in adult micePreprint
Ritschka, B., Knauer-Meyer, T., Mas, A., Plassat, J., Gonçalves, D. S., Jacobs, H., Pedone, E., Vicino, U. D., Cosma, M. P., & Keyes, W. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/759530 · Cited by 1
Poisa-Beiro, L., Landry, J. J. M., Cherdintsev, A., Kardorff, M., Eckstein, V., Villacorta, L., Zaugg, J. B., Gavin, A., Beneš, V., Raffel, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110467 · Cited by 1
“Clearance of Cdkn2a and p16Ink4a positive cells has been shown to increase healthy lifespan and to improve aging disorders in mice [9,12,27].”
Mai, V.-H., Lê, T. T. M., Choi, S., Seong, G.-H., Cha, H., Lee, Y., & Oh, W. K. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00589 · Cited by 1
HSF1 Regulates Cellular Senescence: Role of the DHRS2-MDM2-p53 Pathway
Yamashita, T. (2020) · Heat shock proteins · doi:10.1007/7515_2020_17 · Cited by 1
Xu, W., Chen, H., Gong, H., Zhao, T., Yang, Y., Wang, F., Huang, N., Yang, M., Gao, N., Li, H., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70220 · Cited by 1
“…can extend the healthspan and overall lifespan of progeroid mice, as well as inhibit various age-related diseases, including but not limited to organ fibrosis, atherosclerosis, and neurodegenerative diseases (Baker et al. 2016; Bussian et al. 2018; Childs et al. 2016; Riessland et al. 2019).”
Bone biology in aging periodontal and peri‐implant tissues
Issa, D. R., Intini, G., & Clark, D. (2026) · Periodontology 2000 · doi:10.1111/prd.70035 · Cited by 2
To G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging
Ishikawa, S., & Ishikawa, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_5 · Cited by 1
Matyushkin, A. I., Иванова, Е. А., & Воронина, Т. А. (2022) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-022-02572-8 · Cited by 1
Katsuumi, G., & Minamino, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00007-9 · Cited by 2
Developmental senescence profiling reveals Eda2r as a common mediator in the core senescence programPreprint
Klein, A., Gonçalves, D. S., Dulac, L., Knauer-Meyer, T., Durik, M., Chan, A. S. L., Birling, M., Rhinn, M., Narita, M., & Keyes, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.685553 · Cited by 1
“Senescence-targeting strategies have typically relied on mouse models engineered to eliminate cells expressing canonical markers such as p16 ( Cdkn2a ) or p21 ( Cdkn1a ) 6–8 .”
Self-citationInhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cellsPreprint
Kim, J. J., Brunetti, B., Kumar, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.12.612728 · Cited by 1
Minton, K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.16 · Cited by 1
Majeed, Y., Halabi, N. M., Engelke, R., Sarwath, H., Al-Noubi, M. N., Choi, S., Al-Malki, A., Agha, M. V., Vakayil, M., Chouchane, L., et al. (2025) · eLife · doi:10.7554/elife.109214 · Cited by 1
SanMartín, C. D., Salech, F., Ponce, D. P., Concha-Cerda, J., Romero-Hernández, E., Liabeuf, G., Rogers, N. K., Murgas, P., Bruna, B., More, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087364 · Cited by 2
p16 High senescence restricts totipotent potential during somatic cell reprogrammingPreprint
Grigorash, B. B., van Essen, D., Grosse, L., Emelyanov, A., Kanzler, B., Molina, C., Lopez, E., Demidov, O. N., Garrido, C., Saccani, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.24.504108 · Cited by 1
“…senescent cells as one of the key drivers of aging-induced tissue deterioration, while removal of some senescent cells showed great promise in ameliorating several age-related conditions and extending life span in mice (Baker et al., 2011)(Baker et al., 2016)(ChiIds et al., 2017)(Xu et al., 2018).”
BackgroundDurik, M., Karout, M., Gonçalves, D. S., Knauer-Meyer, T., Spiegelhalter, C., Messaddeq, N., Seehawer, M., Stephan, P., Bulavin, D. V., Hérault, Y., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.08.002 · Cited by 3
Self-citationRzeski, W., & Rzeska, W. (2026) · Nutrients · doi:10.3390/nu18152511 · Cited by 2
Systematic transcriptomic analysis and temporal modelling of the senescent human fibroblastPreprint
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Shanley, D., & Wordsworth, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.16.504144 · Cited by 1
“Mul6ple studies now suggest that the accumula6on of senescent cells is causal in ageing (Childs et al., 2015; Mylonas & O'Loghlen, 2022; van Deursen, 2014; Wlaschek et al., 2021), and their abla6on extends healthspan and mean lifespan in rodents (Baker et al., 2016; Baker et al., 2011).”
BackgroundHydrogen Sulfide and the Kidney
Kasinath, B. S., & Lee, H. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0991-6_2 · Cited by 2
Hepatic regeneration in aging: Cell type plasticity and redundancies
Li, C., Chalmers, T. J., Wong, A. S. A., Zhou, M., Marinova, M. B., Bertoldo, M. J., & Wu, L. E. (2020) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2020.07.002 · Cited by 1
González-Meljem, J. M., Haston, S., Gallage, S., & Innes, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-95387-8_3 · Cited by 1
The boundaries of normal kidney tissue for biomedical research
Hodgin, J. B., Menon, R., & Bitzer, M. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001069 · Cited by 2
Wang, X., Sun, H., Xiao, W., Zhang, Y., Lu, X., Gong, Z., Li, D., Liu, S., Xia, X., Wang, H., et al. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.12.001 · Cited by 1
“In human NP cells experiments, cellular ageing was evaluated by detecting the levels of ageing-associated markers p16INK4a, IL-6, and MMP-3 via RT-qPCR [43 – 45].”
Linked regulation of genome integrity and senescence-associated inflammation by p53Preprint
Miller, K. N., Li, B., Pierce-Hoffman, H. R., Patel, S., Lei, X., Rajesh, A., Teneche, M. G., Havas, A. P., Gandhi, A., Macip, C. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.20.567963 · Cited by 1
Haj‐Mirzaian, A., Afshari, K., & Abdolghaffari, A. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_24 · Cited by 3
Patel, M., Kumar, S., Dugam, P., Singh, A., & Yadav, P. N. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00041 · Cited by 2
Faculty Opinions recommendation of Astrocyte senescence: Evidence and significance.
Rattan, S. I. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735180286.793557427 · Cited by 1
Bridging Biochemistry and Aging: A Journey Towards Prolonged Health span
Panchal, N. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3226 · Cited by 2
The Geriatrician’s Perspective on Surgery in the Geriatric Population
Ong, T. D., Huang, J. C.-S., Crawford, C. A. G., & Bennett, K. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-66878-9_8 · Cited by 2
The therapeutic potential of natural killer (NK) cells to combat aging and age-related diseases
Bari, R., Kang, L., Gosiewska, A., & HARIRI, R. J. (2026) · Discover Immunity. · doi:10.1007/s44368-026-00021-2 · Cited by 2
Mitin, N., Entwistle, A., Knecht, A. K., Strum, S. L., Ross, A., Nyrop, K. A., Muss, H. B., Tsygankov, D., & Raffaele, J. M. (2023) · medRxiv · doi:10.1101/2023.08.25.23294589 · Cited by 1
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
(2020) · doi:10.1101/2020.06.29.177527 · Cited by 3
Effects of senescence on astrocyte to brain endothelial cell signaling
Guo, S., Hamanaka, G., Zhang, F., Lee, J. C. L., Park, J.-H., Li, W., Arai, K., & Lo, E. H. (2025) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.70013 · Cited by 2
Biological markers of aging across the menopause transition: current evidence
Castaneda, R., Uddenberg, E. R., Andrade, M. D. H., Meek, J. L., Frankhouser, K. N., Faubion, S. S., Chini, E. N., LeBrasseur, N. K., Brar, P., & SHUFELT, C. L. (2026) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002802 · Cited by 2
A framework for addressing senescent cell burden in the osteoarthritic knee
Chin, A. F., Han, J., Gray-Gaillard, E. F., Michel, J. H., & Elisseeff, J. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00010-9 · Cited by 3
Immune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 6
Characteristics of senescent cells
Schmitt, R., & Melk, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00035-4 · Cited by 1
Yang, G., Heissenberger, C., Kos-Braun, I. C., Polacek, N., Grillari, J., Schosserer, M., & Koš, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.01.019653 · Cited by 1
Potential Applications of Aptamers for Targeting Senescent Cells
Leonardi, A., Pacifico, F., & Crescenzi, E. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_10 · Cited by 1
Expression of Senescence-Associated Secretory Phenotype in Senescent Gingival Fibroblasts
Lee, S.-I. (2023) · Journal of dental hygiene science · doi:10.17135/jdhs.2023.23.2.169 · Cited by 1
Kitaeva, K. V., Solovyeva, V. V., Blatt, N. L., & Rizvanov, A. A. (2023) · doi:10.20944/preprints202312.1823.v1 · Cited by 7
L’élimination des cellules sénescentes : vers un avenir meilleur ?
Chauvet, V., Jouaville, S., Garbez, N., & Martins, I. (2016) · médecine/sciences · doi:10.1051/medsci/20163211023 · Cited by 1
Cherqui, U., Sopher, I., Akiva, H., Menahem, O., Kopitman, E., Blecher‐Gonen, R., Keren‐Shaul, H., Rachmian, N., Mayo, A., Alon, U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.14.688272 · Cited by 1
From germline immortality to somatic rejuvenation: Unlocking the ovarian blueprint for longevity
Chiavellini, P., & Sebastiano, V. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003804 · Cited by 2
“DNA damage accumulates, epigenetic regulation becomes unstable, mitochondria lose efficiency, senescent cells accumulate [1,2], and regenerative capacity wanes, together with many other categorized hallmarks of aging [3,4] (Fig 1).”
Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions
Chmielewski, P. P. (2026) · Biogerontology · doi:10.1007/s10522-026-10477-2 · Cited by 3
“Intermittent clearance of senescent cells delays multiple age-associated pathologies and improves health-span in mice (Baker et al. 2011; 2016; Chang et al. 2016).”
InfluentialDou, X., Long, Q., Liu, S., Zou, Y., Fu, D., Chen, X., Xu, Q., Wang, C., Ren, X., Zhang, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.21203/rs.3.rs-1966019/v1 · Cited by 2
Meta-analysis reveals reproducible rapamycin-induced shifts in the mouse gut microbiomePreprint
Ortega-Matienzo, A., Meiners, F., Newels, P., Zude, I., Fuellen, G., & Barrantes, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.12.675777 · Cited by 1
Jeong, M., Lee, H., Ko, T.-H., Choi, S. J., Oh, W., & Kim, S. (2025) · Rejuvenation Research · doi:10.1089/rej.2024.0085 · Cited by 1
Fan, Q., Chen, K., Zhao, W., Diao, X., Xia, Z., Wu, C., Du, Y., Zhao, H., & Liu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3035500/v1 · Cited by 1
Physiological and Pathological Vascular Aging
Pitrez, P. R., Aires, H. I. R., Tomé, I., Ferreira, R. S., & Ferreira, L. (2018) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-319-99319-5_3 · Cited by 3
Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer
Muss, H. B., Wardell, A. C., Deal, A. M., Nyrop, K. A., Ross, A., Abdou, Y. G., Aldrich, J. D., Cary, L. A., Dees, E. C., Reeder-Hayes, K. E., et al. (2026) · Aging and Cancer · doi:10.1002/aac2.70022 · Cited by 2
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.